Sanna Bastiano's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Apr 14, 2023
- Accession no.
- 0001209191-23-024312
- Filed
- Apr 14, 2023
- Trade date
- Apr 12, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $2.47M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sanna BastianoCIK 0001829069 | Officer (EVP, Cell & Genetic Therapies) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 | Common Stock | SSaleDisposed | −874 | $325.70F2,F3 | −$284,661.8 | 46,406 | Direct | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −4,068 | $326.45F2,F4 | −$1,327,998.6 | 42,338 | Direct | |
| Apr 12, 2023 | Common Stock | SSaleDisposed | −2,625 | $327.43F2,F5 | −$859,503.75 | 39,713 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $325.70 (range $325.00 to $325.98).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $326.45 (range $326.00 to $326.99).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $327.43 (range $327.01 to $327.91).
Referenced by the price of 1 transaction in Table I.